NASDAQ : OVID
Ovid Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.56 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 499.96M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Ovid Therapeutics Inc. (OVID) reported revenue of 1.58M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.58M | 7.25M | 566.00K | 392.00K | 1.50M | 208.38M |
| Gross Profit | 1.58M | 7.25M | 566.00K | 392.00K | 1.50M | 208.38M |
| Selling, General & Admin | 26.05M | 24.11M | 23.88M | 29.59M | 32.43M | 37.23M |
| Research & Development | 33.60M | 25.58M | 35.07M | 28.39M | 24.62M | 46.94M |
| Operating Expenses | 59.64M | 49.69M | 58.95M | 57.97M | 57.05M | 84.17M |
| Operating Income | -58.06M | -42.44M | -58.38M | -57.58M | -55.55M | 124.21M |
| Interest & Investment Income | 3.45M | 2.03M | 3.92M | 4.94M | ||
| Other Non Operating Income (Expenses) | -631.00K | 147.00K | 30.00M | -1.00K | 1.83M | -45.69K |
| EBT Excluding Unusual Items | -55.24M | -40.27M | -24.47M | -52.64M | -53.71M | 124.16M |
| Merger & Restructuring Charges | -3.50M | -1.70M | ||||
| Gain (Loss) on Sale of Investments | 21.05M | 21.05M | 3.34M | 2.00M | -454.81K | |
| Other Unusual Items | -300.00K | 1.80M | -1.80M | |||
| Pretax Income | -34.49M | -17.41M | -26.43M | -52.34M | -54.17M | 124.16M |
| Income Tax Expense | 1.33M | |||||
| Net Income | -34.49M | -17.41M | -26.43M | -52.34M | -54.17M | 122.83M |
| Preferred Dividends & Other Adjustments | -14.00K | -272.00K | -458.00K | -911.00K | 3.00M | |
| Net Income to Common | -34.48M | -17.14M | -25.98M | -51.43M | -54.17M | 119.84M |
| Shares Outstanding (Basic) | 121.53M | 73.74M | 70.91M | 70.58M | 70.42M | 67.48M |
| Shares Outstanding (Diluted) | 121.53M | 73.74M | 70.91M | 70.58M | 70.42M | 68.07M |
| EPS (Basic) | -0.28 | -0.23 | -0.37 | -0.73 | -0.77 | 1.78 |
| EPS (Diluted) | -0.28 | -0.23 | -0.37 | -0.73 | -0.77 | 1.76 |
| Free Cash Flow | -54.77M | -38.33M | -56.03M | -45.82M | -56.45M | 118.43M |
| Free Cash Flow Per Share | -0.45 | -0.52 | -0.79 | -0.65 | -0.80 | 1.74 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -3,667.59% | -585.20% | -10,315.37% | -14,689.03% | -3,696.44% | 59.61% |
| Profit Margin | -2,177.95% | -236.38% | -4,589.22% | -13,119.39% | -3,604.66% | 57.51% |
| Free Cash Flow Margin | -3,460.08% | -528.60% | -9,898.76% | -11,689.03% | -3,756.55% | 56.83% |
| EBITDA | -57.97M | -42.17M | -57.77M | -57.01M | -55.04M | 124.45M |
| EBITDA Margin | 59.72% | |||||
| D&A For EBITDA | 84.00K | 273.00K | 613.00K | 568.00K | 512.50K | 237.08K |
| EBIT | -58.06M | -42.44M | -58.38M | -57.58M | -55.55M | 124.21M |
| EBIT Margin | 59.61% | |||||
| Effective Tax Rate | 1.07% | |||||
| Revenue as Reported | 1.58M | 7.25M | 566.00K | 392.00K | 1.50M | 208.38M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 11.33M | 13.15M | 26.30M | 27.04M | 44.87M | 187.80M |
| Short-Term Investments | 105.89M | 56.48M | 26.77M | 78.79M | 84.13M | |
| Cash & Short-Term Investments | 117.22M | 69.64M | 53.08M | 105.83M | 129.00M | 187.80M |
| Prepaid Expenses | 6.40M | 4.73M | 2.87M | 3.76M | 2.38M | 2.68M |
| Other Current Assets | 1.00K | |||||
| Total Current Assets | 123.62M | 74.37M | 55.94M | 109.60M | 131.38M | 190.48M |
| Property, Plant & Equipment | 11.18M | 11.86M | 13.23M | 14.66M | 16.07M | 242.76K |
| Long-Term Investments | 95.24M | 62.77M | 20.97M | 17.63M | 5.62M | 1.63M |
| Other Intangible Assets | 92.00K | 200.00K | 222.10K | 260.13K | ||
| Other Long-Term Assets | 1.93M | 1.93M | 1.93M | 1.94M | 1.97M | 1.93M |
| Total Assets | 231.97M | 150.93M | 92.17M | 144.03M | 155.27M | 194.54M |
| Accounts Payable | 4.07M | 1.96M | 3.19M | 3.70M | 1.95M | 7.13M |
| Accrued Expenses | 4.24M | 4.90M | 5.99M | 6.52M | 4.50M | 7.67M |
| Current Portion of Leases | 1.48M | 1.43M | 1.34M | 1.25M | 533.95K | |
| Total Current Liabilities | 9.98M | 8.29M | 10.52M | 11.47M | 6.99M | 14.80M |
| Long-Term Leases | 11.23M | 11.99M | 13.42M | 14.76M | 16.00M | |
| Other Long-Term Liabilities | 872.00K | 30.00M | ||||
| Total Liabilities | 22.08M | 20.27M | 23.94M | 56.23M | 22.99M | 14.80M |
| Common Stock | 185.00K | 130.00K | 71.00K | 71.00K | 70.47K | 70.36K |
| Additional Paid-In Capital | 564.16M | 452.44M | 372.49M | 365.59M | 357.77M | 351.03M |
| Retained Earnings | -353.71M | -321.71M | -304.30M | -277.87M | -225.53M | -171.36M |
| Comprehensive Income & Other | -750.00K | -202.00K | -35.00K | -42.19K | ||
| Total Common Equity | 209.89M | 130.66M | 68.23M | 87.80M | 132.27M | 179.75M |
| Shareholders' Equity | 209.89M | 130.66M | 68.23M | 87.80M | 132.27M | 179.75M |
| Total Liabilities & Equity | 231.97M | 150.93M | 92.17M | 144.03M | 155.27M | 194.54M |
| Total Debt | 12.71M | 13.42M | 14.76M | 16.00M | 16.54M | |
| Net Cash (Debt) | 157.05M | 77.03M | 38.32M | 89.83M | 112.47M | 187.80M |
| Net Cash Per Share | 1.29 | 1.04 | 0.54 | 1.27 | 1.60 | 2.76 |
| Filing Date Shares Outstanding | 195.30M | 131.87M | 71.08M | 70.71M | 70.49M | 70.37M |
| Total Common Shares Outstanding | 184.76M | 130.18M | 71.01M | 70.69M | 70.47M | 70.36M |
| Working Capital | 113.64M | 66.08M | 45.42M | 98.12M | 124.39M | 175.68M |
| Book Value Per Share | 1.14 | 1.00 | 0.96 | 1.24 | 1.88 | 2.55 |
| Tangible Book Value | 209.89M | 130.66M | 68.13M | 87.60M | 132.05M | 179.49M |
| Tangible Book Value Per Share | 1.14 | 1.00 | 0.96 | 1.24 | 1.87 | 2.55 |
| Machinery | 1.53M | 1.53M | 1.53M | 1.46M | 1.42M | 504.96K |
| Leasehold Improvements | 306.00K | 306.00K | 306.00K | 306.00K | 306.31K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -34.49M | -17.41M | -26.43M | -52.34M | -54.17M | 122.83M |
| Depreciation & Amortization | 84.00K | 273.00K | 613.00K | 568.00K | 1.38M | 237.08K |
| Asset Writedown & Restructuring Costs | 7.30M | |||||
| Loss (Gain) From Sale of Investments | -21.12M | -21.05M | -3.35M | -2.00M | 454.81K | |
| Stock-Based Compensation | 4.78M | 4.81M | 6.28M | 7.29M | 6.56M | 5.05M |
| Other Operating Activities | -1.17M | -844.00K | -32.91M | -1.68M | -1.22M | |
| Change in Accounts Payable | 122.00K | -1.23M | -512.00K | 1.75M | -5.17M | 1.70M |
| Change in Unearned Revenue | -718.00K | -12.38M | ||||
| Change in Other Net Operating Assets | -2.26M | -2.87M | 362.00K | 636.00K | -3.06M | -6.13M |
| Operating Cash Flow | -54.77M | -38.33M | -55.96M | -45.78M | -55.23M | 118.61M |
| Capital Expenditures | -71.00K | -40.00K | -1.22M | -184.01K | ||
| Sale (Purchase) of Intangibles | -90.00K | -97.00K | -194.40K | -5.40K | ||
| Investment in Securities | -147.80M | -49.85M | 54.75M | -2.44M | -85.46M | -1.63M |
| Other Investing Activities | 1.00K | -1.00K | -1.00M | |||
| Investing Cash Flow | -147.80M | -49.85M | 54.59M | -2.58M | -87.88M | -1.82M |
| Issuance of Common Stock | 185.78M | 75.21M | 622.00K | 535.00K | 180.66K | 925.40K |
| Other Financing Activities | 30.00M | -21.31K | ||||
| Financing Cash Flow | 185.78M | 75.21M | 622.00K | 30.54M | 180.66K | 904.08K |
| Foreign Exchange Rate Adjustments | -293.00K | -167.00K | ||||
| Miscellaneous Cash Flow Adjustments | 1.00K | |||||
| Net Cash Flow | -17.09M | -13.15M | -740.00K | -17.83M | -142.93M | 117.69M |
| Free Cash Flow | -54.77M | -38.33M | -56.03M | -45.82M | -56.45M | 118.43M |
| Free Cash Flow Margin | -3,460.08% | -528.60% | -9,898.76% | -11,689.03% | -3,756.55% | 56.83% |
| Free Cash Flow Per Share | -0.45 | -0.52 | -0.79 | -0.65 | -0.80 | 1.74 |
| Levered Free Cash Flow | -33.12M | -25.64M | -29.90M | -25.89M | -36.24M | 75.60M |
| Unlevered Free Cash Flow | -33.12M | -25.64M | -29.90M | -25.89M | -36.24M | 75.60M |
| Change in Working Capital | -2.86M | -4.10M | -150.00K | 2.39M | -8.23M | -16.81M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 501.72M | 212.20M | 66.30M | 227.59M | 131.07M | 218.58M |
| Enterprise Value | 344.67M | 200.36M | 18.66M | 156.82M | 9.46M | 16.80M |
| Last Close Price | 2.54 | 1.63 | 0.93 | 3.22 | 1.86 | 3.21 |
| PE Ratio | 1.82 | |||||
| Forward PE | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | |
| PS Ratio | 313.36 | 29.26 | 117.14 | 580.59 | 87.22 | 1.05 |
| PB Ratio | 2.24 | 1.62 | 0.97 | 2.59 | 0.99 | 1.22 |
| P/TBV Ratio | 2.36 | 1.62 | 0.97 | 2.60 | 0.99 | 1.22 |
| P/FCF Ratio | 1.85 | |||||
| P/OCF Ratio | 1.84 | |||||
| EV/Sales Ratio | 214.15 | 27.63 | 32.98 | 400.05 | 6.29 | 0.08 |
| EV/EBITDA Ratio | 0.14 | |||||
| EV/EBIT Ratio | 0.14 | |||||
| EV/FCF Ratio | 0.14 | |||||
| Debt / Equity Ratio | 0.06 | 0.10 | 0.22 | 0.18 | 0.12 | |
| Net Debt / Equity Ratio | -0.75 | -0.59 | -0.56 | -1.02 | -0.85 | -1.04 |
| Net Debt / EBITDA Ratio | 2.71 | 1.83 | 0.66 | 1.58 | 2.04 | -1.51 |
| Net Debt / FCF Ratio | 2.87 | 2.01 | 0.68 | 1.96 | 1.99 | -1.59 |
| Asset Turnover | 0.01 | 0.06 | 0.01 | 0.00 | 0.01 | 1.54 |
| Quick Ratio | 11.74 | 8.40 | 5.04 | 9.22 | 18.45 | 12.69 |
| Current Ratio | 12.39 | 8.97 | 5.32 | 9.55 | 18.79 | 12.87 |
| Return on Equity (ROE) | -25.96% | -17.51% | -33.88% | -47.57% | -34.72% | 109.98% |
| Return on Assets (ROA) | -23.46% | -21.82% | -30.90% | -24.05% | -19.85% | 57.40% |
| Return on Invested Capital (ROIC) | -72.03% | -81.34% | -195.23% | -280.45% | ||
| Return on Capital Employed (ROCE) | -26.20% | -29.80% | -71.50% | -43.40% | -37.50% | 69.10% |
| Earnings Yield | -11.04% | -8.21% | -39.87% | -23.00% | -41.33% | 56.20% |
| FCF Yield | -11.04% | -18.07% | -84.50% | -20.13% | -43.07% | 54.18% |
| Buyback Yield / Dilution | -71.09% | -3.99% | -0.46% | -0.22% | -3.46% | -16.45% |